| Truman Franklin King, MD | |
|
1727 Kirby Parkway Suite 200, Memphis, TN 38120 | |
| (901) 767-3810 | |
| (901) 682-2920 |
| Full Name | Truman Franklin King |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 42 Years |
| Location | 1727 Kirby Parkway Suite 200, Memphis, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336148600 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 14969 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Memorial Hospital | Memphis, TN | Hospital |
| Methodist Healthcare Memphis Hospitals | Memphis, TN | Hospital |
| Baptist Memorial Hospital Desoto | Southaven, MS | Hospital |
| Methodist Healthcare - Olive Branch Hospital | Olive branch, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Women's Care Center Of Memphis, Mpllc | 7012803505 | 24 |
News Archive
It's estimated that one in 100 people in the United States are living with celiac disease, but there are only a handful of celiac centers throughout the country. In response to a growing need for educational materials, clinicians at Beth Israel Deaconess Medical Center's Celiac Center have launched CeliacNow, a nutritional management website designed to maximize the health and wellbeing of people living with celiac disease and other gluten-related disorders.
It is often suggested that the results of clinical trials are affected by the fact that the patients who volunteer for a trial are more likely to take their medication effectively than those in standard care. This supposition is, however, strongly refuted in the results of a new study revealed at the British Pharmaceutical Conference in Manchester.
Researchers at the Fralin Biomedical Research Institute at VTC have identified a cellular response in mice to mild traumatic brain injuries that may lead to seizures.
The Journal of the American Academy of Dermatology (JAAD) has published Phase III data evaluating the safety and efficacy of imiquimod cream at two doses - 2.5% and 3.75% - administered daily on a 2-week treatment cycle. The study demonstrates that both formulations were superior to placebo, and that imiquimod 3.75% on a daily 2-week treatment cycle is superior to imiquimod 2.5% in treating actinic keratosis (AK) on a large surface area - the face or balding scalp.
› Verified 9 days ago
| Entity Name | Women's Care Center Of Memphis, Mpllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720151418 PECOS PAC ID: 7012803505 Enrollment ID: O20040223000808 |
News Archive
It's estimated that one in 100 people in the United States are living with celiac disease, but there are only a handful of celiac centers throughout the country. In response to a growing need for educational materials, clinicians at Beth Israel Deaconess Medical Center's Celiac Center have launched CeliacNow, a nutritional management website designed to maximize the health and wellbeing of people living with celiac disease and other gluten-related disorders.
It is often suggested that the results of clinical trials are affected by the fact that the patients who volunteer for a trial are more likely to take their medication effectively than those in standard care. This supposition is, however, strongly refuted in the results of a new study revealed at the British Pharmaceutical Conference in Manchester.
Researchers at the Fralin Biomedical Research Institute at VTC have identified a cellular response in mice to mild traumatic brain injuries that may lead to seizures.
The Journal of the American Academy of Dermatology (JAAD) has published Phase III data evaluating the safety and efficacy of imiquimod cream at two doses - 2.5% and 3.75% - administered daily on a 2-week treatment cycle. The study demonstrates that both formulations were superior to placebo, and that imiquimod 3.75% on a daily 2-week treatment cycle is superior to imiquimod 2.5% in treating actinic keratosis (AK) on a large surface area - the face or balding scalp.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Truman Franklin King, MD 1727 Kirby Parkway Suite 200, Memphis, TN 38120 Ph: (901) 767-3810 | Truman Franklin King, MD 1727 Kirby Parkway Suite 200, Memphis, TN 38120 Ph: (901) 767-3810 |
News Archive
It's estimated that one in 100 people in the United States are living with celiac disease, but there are only a handful of celiac centers throughout the country. In response to a growing need for educational materials, clinicians at Beth Israel Deaconess Medical Center's Celiac Center have launched CeliacNow, a nutritional management website designed to maximize the health and wellbeing of people living with celiac disease and other gluten-related disorders.
It is often suggested that the results of clinical trials are affected by the fact that the patients who volunteer for a trial are more likely to take their medication effectively than those in standard care. This supposition is, however, strongly refuted in the results of a new study revealed at the British Pharmaceutical Conference in Manchester.
Researchers at the Fralin Biomedical Research Institute at VTC have identified a cellular response in mice to mild traumatic brain injuries that may lead to seizures.
The Journal of the American Academy of Dermatology (JAAD) has published Phase III data evaluating the safety and efficacy of imiquimod cream at two doses - 2.5% and 3.75% - administered daily on a 2-week treatment cycle. The study demonstrates that both formulations were superior to placebo, and that imiquimod 3.75% on a daily 2-week treatment cycle is superior to imiquimod 2.5% in treating actinic keratosis (AK) on a large surface area - the face or balding scalp.
› Verified 9 days ago
Kristin M. Miller, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6750 Poplar Ave, Suite 210, Memphis, TN 38138 Phone: 901-756-6522 Fax: 901-435-0928 | |
Dr. Jason Glenn Williams, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6745 Wolf River Blvd., Memphis, TN 38120 Phone: 901-767-8442 Fax: 901-684-6260 | |
Dr. Owen P. Phillips, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6215 Humphreys Blvd Ste 201, Memphis, TN 38120 Phone: 901-866-8085 Fax: 901-515-3429 | |
Claudia Leonard Moise, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 6215 Humphreys Blvd, Suite 401, Memphis, TN 38120 Phone: 901-767-8448 Fax: 901-684-6260 | |
Dr. Kingsley Ogonna Oraedu, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6025 Walnut Grove Rd, Ste 316, Memphis, TN 38120 Phone: 901-274-9717 Fax: 901-684-2008 | |
Mitchell Scott Mcalister, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2400 Poplar Ave, Suite 501, Memphis, TN 38112 Phone: 901-271-0896 Fax: 901-271-0897 | |
Dr. Dwight Melvyn Moore, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1264 Wesley Dr, Ste 402, Memphis, TN 38116 Phone: 901-396-5577 Fax: 901-396-5585 |